Thrombolysis with recombinant streptokinase in CubaBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7386.448/a (Published 22 February 2003) Cite this as: BMJ 2003;326:448
- Pedro A Lopez-Saura, head of clinical trials ([email protected])
- Centre for Biological Research, PO Box 6162, CP 10600, Havana, Cuba
EDITOR—Analysis of the causes of the low rate (21%) of thrombolysis for acute myocardial infarction in England and Wales described by Mayor would be interesting.1 In Cuba thrombolysis with home manufactured recombinant streptokinase has been widespread since 1993. When this procedure was introduced nationwide, the overall proportion of patients …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial